Capital Advisors Ltd’s Keros Therapeutics KROS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$0	Buy	30 +14	+88%	–	﹤0.01%	1499
2025 Q1	$0	Buy	+16	New	–	﹤0.01%	1469